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Depression and diabetes distress 
in adults with type 2 diabetes: 
results from the Australian National 
Diabetes Audit (ANDA) 2016
Natalie Nanayakkara1,2, Anthony Pease1,2, Sanjeeva Ranasinha1, Natalie Wischer  3, 
Sofianos Andrikopoulos1,4, Jane Speight5,6,7, Barbora de Courten1,2 & Sophia Zoungas1,2,8
This study explores the prevalence of, and factors associated with, likely depression and diabetes 
distress in adults with type 2 diabetes in a large, national sample. Australian National Diabetes Audit 
data were analysed from adults with type 2 diabetes attending 50 diabetes centres. The Brief Case 
find for Depression and Diabetes Distress Score 17 were administered to screen for likely depression 
and diabetes-related distress, respectively. A total of 2,552 adults with type 2 diabetes participated: 
(mean ± SD) age was 63 ± 13 years, diabetes duration was 12 ± 10 years, and HbA1c was 8 ± 2%. 
Twenty-nine percent of patients had likely depression, 7% had high diabetes distress, and 5% had both. 
Difficulty following dietary recommendations, smoking, forgetting medications, and diabetes distress 
were all associated with greater odds of depression whereas higher own health rating was associated 
with lower odds (all p < 0.02). Female gender, increasing HbA1c, insulin use, difficulty following dietary 
recommendations and depression were all associated with greater odds of diabetes distress & older 
age, higher own health rating and monitoring blood glucose levels as recommended were associated 
with lower odds (all p < 0.04). Depression was associated with sub-optimal self-care, while diabetes 
distress was associated with higher HbA1c and sub-optimal self-care.
Driven by ageing, obesity and sedentary lifestyles, type 2 diabetes mellitus (T2DM) currently affects just under 
400 million individuals worldwide and is expected to rise exponentially, affecting 592 million by 20351. Globally, 
depression and diabetes represent the 4th and 8th cause of disability adjusted life years respectively2. Depression 
and distress in T2DM are associated with greater morbidity, mortality and healthcare costs3.
Like many other chronic conditions, T2DM is associated with depression. Depression has been reported 
to affect up to 40% of patients with diabetes4–6. Indeed, individuals with diabetes have a 2–4 fold greater risk 
of depression when compared to individuals without diabetes7. Depression is associated with higher glycated 
haemoglobin (HbA1c)8, higher rates of complications9,10 and mortality11. This association may be mediated by 
sub-optimal self-care12, medication adherence13, health-related quality of life14 and common pathophysiological 
mechanisms via stress and inflammation7. Furthermore, even modest levels of depression are associated with less 
diabetes self-care15. Timely diagnosis and treatment of depression may improve quality of life and increase social 
and workforce participation for patients as well as family, friends and carers16,17.
The negative impact of depression on diabetes may be explained by diabetes distress18,19. Diabetes distress 
refers to the emotional distress related to living with and managing diabetes, not attributable to other causes of 
overall emotional distress or mental health problems19,20. Many adults with diabetes and depressive symptoms 
experience high levels of emotional distress stemming from their concerns and worries about diabetes21.
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 Population-based surveys demonstrate that that both depression and diabetes distress are prevalent among 
adults with type 2 diabetes22,23. Despite this, there is limited data exploring factors associated with depression 
and diabetes distress in Australian people with type 2 diabetes. We hypothesised that significant levels of depres-
sion and diabetes distress in adults with T2DM attending diabetes clinics, are related to demographic, self-care, 
clinical and healthcare factors. Thus, this large-scale, national, cross-sectional clinic-based study examined the 
prevalence and factors associated with depression and diabetes distress in adults with T2DM attending diabetes 
centres across Australia.
Methods
Participants and procedures. Data were analysed from the Australian National Diabetes Audit (ANDA) 
including patients from 50 diabetes centres across Australia. The state and territory location of participating 
centres is presented in Supplementary Table 1. Validated screening instruments were administered during the 
consultation by clinicians on the day of the survey.
Only adults with T2DM were eligible to be included in the current study; adults and children with type 1 dia-
betes, women with gestational diabetes and those with other forms of diabetes were excluded.
De-identified data were collected by participating diabetes centres during a single 4-week survey period (May/
June 2016). Patients were under the care of endocrinologists, general specialists, general practitioners and dia-
betes nurse educators. Health professionals from participating centres interviewed patients, reviewed medical 
records and pathology results before recording the information in a standardised data collection form.
All missing data, invalid entries and discrepancies were clarified with the relevant diabetes centres. The con-
duct of ANDA and use of de-identified data for research purposes was approved by the Monash Health Human 
Research Ethics Committee and all research was performed in accordance with relevant guidelines/regulations.
Explanatory Variables. Pre-specified demographic data (gender, date of birth) and clinical variables (dia-
betes duration [years], smoking, health professional attendance, glycated haemoglobin A1c [(HbA1c) (within 12 
months)], physical activity, diet and medication adherence) were obtained for patients with T2DM. Age and dia-
betes duration at survey were calculated as year of survey (2016) minus year of birth or year of diabetes diagnosis, 
respectively. Current smoking status was ascertained at the time of surveys as was physical activity, with sufficient 
activity defined as ≥150 total minutes per week as per National Physical Activity Guidelines for Australians24. 
Own Health State Rating was determined on a visual analogue scale (0–100) based on patients’ subjective assess-
ment of their health on the day of survey. Patients were considered to be receiving treatment for depression if 
they were either undergoing counselling by either a psychologist or psychiatrist and/or taking antidepressant 
medications (not prescribed for peripheral neuropathy).
Outcome variables. Depression. The Brief Case find for Depression (BCD) was administered to screen 
for likely depression25. Depression was considered likely if at least two affirmative answers were indicated, one in 
each category of the BCD.
Diabetes Distress. The Diabetes Distress Score 17 (DDS17) was administered to screen for diabetes-related dis-
tress26. Patients were first asked two screening questions, if at least one answer was positive, patients were asked 
to proceed to the DDS17 questionnaire. The DDS17 questionnaire assesses difficulties related to diabetes expe-
rienced during the past month, graded on a Likert scale from 1 (not a problem) to 6 (very serious problem). 
The DDS17 yields a composite score as well as four subscale scores, each exploring a different source of diabetes 
distress: emotional burden, physician-related distress, regimen-related distress, and interpersonal distress. An 
overall mean score <2.0 indicates little to no diabetes distress, from 2.0–2.9 indicates moderate diabetes distress, 
and ≥3.0 indicates a high diabetes distress27. Diabetes distress was considered as a dichotomous variable, with 
patients deemed to have high diabetes distress if DDS17 scores were ≥3.
Statistical analysis. Categorical variables were summarised as percentages and differences between sub-
groups analysed using χ2 test. Continuous variables were reported as means with standard deviations (SD) or 
as medians with interquartile ranges (IQR) and tested for normality to determine appropriate statistical analysis 
(parametric or non-parametric). T tests were performed for normally distributed data and Mann-Whitney U tests 
for non-normally distributed data. Logistic regression was used to examine factors (age, gender, language, dura-
tion, HbA1c, physical activity, diet, smoking, insulin use, medication adherence, glucose monitoring, own health 
rating and health professional attendance) associated with likely depression and high diabetes distress (as per the 
categories above). The selection of variables to be entered into each model was based on identifying all variables 
with possible prognostic importance for the outcomes of interest (and/or exhibiting p < 0.10 on univariate anal-
ysis). All analyses were adjusted for age and gender. Patients with missing data for a particular variable were not 
included in analyses pertaining to that variable, but were not excluded from other analyses where relevant data 
were available. A two-sided significance level of 0.05 was considered statistically significant. All analyses were 
performed using Stata software version 14.2 (StataCorp, Texas, USA).
Data Sharing Statement. Application for datasets generated during and/or analysed during the current 
study may be considered by the corresponding author on reasonable request.
Results
Data from 2,552 adults (≥18 years of age) with T2DM were analysed. Mean ( ± SD) age was 63 ± 13 years, T2DM 
duration was 12 ± 10 years, and HbA1c was 8.0 ± 2.0%. Country of birth was reported as Australia by most 
patients (65%) followed by England (4%) and New Zealand (3%). No depression and little to moderate dia-
betes distress was reported by 1663 adults (65%), no depression and high diabetes distress by 56 adults (2%), 
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depression and little to moderate diabetes distress by 578 adults (23%), and depression and high diabetes distress 
by 120 adults (5%). Participant characteristics are described in Table 1.
Likely Depression. Thirty percent of adults with T2DM had a BCD score suggesting likely depression, more 
than half of whom (17% of total) were not receiving any treatment, while just under half (13% of total) were 
receiving counselling and-/or pharmacotherapy (Fig. 1). Age, female gender, higher HbA1c, insufficient physical 
activity, difficulty following dietary recommendations, smoking, insulin use, forgetting medications, not monitor-
ing blood glucose levels, treatment for depression, lower own health rating and diabetes distress were significantly 
associated with depression (univariable p < 0.010, Table 2). In multivariable analysis adjusting for anti-depressant 
treatment, difficulty following dietary recommendations, current smoking, forgetting medications, and diabe-
tes distress were associated with greater odds of depression whereas higher own health rating was associated 
with lower odds of depression (all p < 0.002, Table 2). Female gender was not associated with increased risk of 
Characteristic
Likely depression
Yes No
N = 2552
Diabetes Distress Diabetes Distress
Yes No Yes No
Participants (n) 126 572 51 1668
Age to 2016 (years), mean (SD) 56.4 ± 11.3 60.5 ± 12.6 54.7 ± 13.0 64.1 ± 12.5
Male, n (%) 51 (41) 306 (54) 19 (37) 954 (57)
Non-English speaking2 2 (2) 29 (5) 0 (0) 88 (5)
Diabetes duration (years), mean (SD) 12.2 ± 8.3 11.8 ± 9.6 10.8 ± 7.2 11.7 ± 9.7
Lifestyle
Sufficient Physical Activity3, n (%) 19 (15) 176 (31) 15 (29) 705 (42)
Difficulties following the recommended diet, n (%) 91 (72) 280 (49) 36 (71) 525 (31)
Current smoking, n (%) 26 (21) 100 (18) 8 (15.7) 164 (9.8)
Diabetes management
HbA1c1 (%), mean (SD) 9.3 ± 2.1 8.4 ± 1.9 9.3 ± 2.0 8.1 ± 1.8
HbA1c1 (mmol/mol), mean (SD) 78.4 ± 23 68.1 ± 20.7 78.6 ± 20.8 65.2 ± 20.1
Above target HbA1c (7.0%), n (%) 97 (83) 396 (74) 41 (84) 1057 (68)
Insulin, n (%) 96 (76) 362 (63) 38 (74) 915 (55)
Do you forget to take your medications? n (%) 66 (52) 209 (37) 24 (47) 360 (22)
Blood glucose testing
Tests blood glucose level as often as recommended 58 (46) 159 (28) 19 (37) 407 (25)
Does not check blood glucose level as often as 
recommended 62 (49) 368 (65) 30 (59) 1,157 (70)
Unsure of recommendation 6 (5) 39 (7) 2 (4) 94 (6)
Health professional attendances3
Diabetes specialist review4 85 (67) 377 (66) 37 (73) 1,059 (64)
Diabetes educator review4 81 (64) 436 (76) 41 (80) 1,201 (72)
Dietitian, n (%) 58 (46) 306 (54) 27 (53) 811 (49)
Podiatrist, n (%) 88 (70) 378 (66) 31 (61) 1,084 (65)
Ophthalmologist and/or Optometrist, n (%) 96 (76) 471 (82) 44 (86) 1,370 (82)
Physical health
Own health state rating (0–100), mean (SD) 43 ± 20 57 ± 21 57 ± 18 70 ± 18
Psychological health
Depression5, n (%) 126 (100) 572 (100) 0 (0) 0 (0)
Treated for depression, n (%) 60 (48) 228 (40) 17 (33) 282 (17)
Taking antidepressants6, n (%) 54 (43) 189 (33) 15 (29) 249 (15)
Undergoing counselling, n (%) 26 (21) 103 (18) 8 (16) 97 (6)
Diabetes Distress overall score7 126 (100) 0 (0) 51 (100) 0 (0)
Emotional distress score6, n (%) 120 (95) 89 (16) 44 (86) 69 (4)
Physician- related distress score 6, n (%) 50 (40) 9 (2) 19 (37) 7 (0.4)
Regimen- related distress score 6, n (%) 110 (87) 78 (14) 44 (86) 57 (3)
Interpersonal distress score6, n (%) 83 (66) 37 (6) 27 (53) 29 (2)
Table 1. Participant characteristics by depression and diabetes distress status. 1Within 6 months of survey; 
2defined as requirement of interpreter for appointment; 3Sufficient physical activity for health benefit is defined 
as ≥150 total minutes per week; 4Attended within the last 12 months; 5As indicated by the Brief Case-Find for 
Depression (BCD); 6Not prescribed for peripheral neuropathy; 7As indicated by Diabetes Distress 17 Score; 
*Categorical variables were summarised as percentages.
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depression after adjustment for potential confounding factors such as age, insulin use, HbA1c, smoking status, 
medication adherence, diet difficulty, physical activity, glucose monitoring, use of antidepressant medications or 
counselling, own health rating and diabetes distress score [0.96 (0.77–1.18), p = 0.672].
Diabetes Distress. Seven percent of patients had a DDS 17 score suggesting high diabetes distress. Age, 
female gender, higher HbA1c, insulin use, smoking, forgetting medications, difficulty following dietary rec-
ommendations, insufficient physical activity, not monitoring blood glucose levels, depression, treatment for 
depression and lower own health rating were significantly associated with diabetes distress (univariable p < 0.032 
Table 3). In multivariable analysis, female gender, higher HbA1c, insulin use, difficulty following dietary recom-
mendations, and depression were associated with greater odds of diabetes distress whereas older age, higher own 
health rating and monitoring blood glucose levels as recommended were associated with lower odds of diabetes 
distress (all p < 0.04, Table 3).
Younger age, insulin use, a requirement for an interpreter, difficulty following dietary recommendations, 
higher HbA1c, depression, treatment for depression, and lower own health rating were associated with greater 
odds of emotional distress after adjustment for gender, current smoking, forgetting medications, sufficient physi-
cal activity, diabetes specialist review, and not monitoring blood glucose levels (Supplementary Table 2). Younger 
age, female gender, insufficient physical activity, depression and lower own health rating were associated with 
greater odds of physician-related distress on adjusted analysis (Supplementary Table 2). Younger age, require-
ment for an interpreter, forgetting medications, difficulty following dietary recommendations, higher HbA1c, 
depression, treatment for depression, not monitoring blood glucose levels and lower own health rating were 
associated with greater odds of regimen-related distress on adjusted analysis (Supplementary Table 2). Younger 
age, female gender, insulin use, difficulty following dietary recommendations, higher HbA1c, depression, treat-
ment for depression and lower own health rating were associated with greater odds of interpersonal distress on 
adjusted analysis (Supplementary Table 2). Female gender was associated with increased risk of diabetes distress 
after adjustment for potential confounding factors such as age, insulin use, HbA1c, smoking status, interpreter 
use, medication adherence, diet difficulty, physical activity, glucose monitoring, likely depression, use of antide-
pressant medications or counselling and own health rating [1.59 (1.11–2.27), p = 0.012]. Factors associated with 
diabetes distress among women and men with type 2 diabetes slightly differed with a greater number among 
women (younger age, insulin use, higher HbA1c, requirement for interpreter, diet difficulty, being unsure of 
glucose monitoring recommendations, likely depression and lower own health rating) than among men (higher 
HbA1c, diet difficulty, likely depression and lower own health rating) (data not shown).
Discussion
In this large national study, we found that approximately one third of patients with T2DM attending diabetes 
centres suffer from likely depression and diabetes distress, and that a substantial proportion remain untreated. 
Patients with depression or diabetes distress were less likely to achieve the recommendations for smoking cessa-
tion, diet, physical activity, and blood glucose monitoring. These effects remained significant after adjustment for 
other relevant confounders.
Likely Depression. It is of concern that a significant proportion of our patients with T2DM are likely to have 
comorbid depression with the majority untreated. The rate of depression we observed was comparable to that 
of other studies from Australia22, USA28 and China29,30. These findings underscore the importance of guidelines 
recommending clinicians screen, identify and treat depression at the earliest stages of diabetes31.
The brief case find for depression is a screening tool for use in general medical and geriatric patients. It has 
been validated in populations with chronic illness where it was found to have good sensitivity and agreement 
with other screening tools for depression such as the Primary Care Evaluation of Mental Disorders (PRIME-MD) 
and the Hospital Anxiety and Depression Scale (HADS)32,33. Although clinical psychiatric interview remains 
the gold standard for diagnosis of depression, this is not usually feasible in the setting of an outpatient diabetes 
consultation. The BCD can be administered quickly to those at risk of depression before referral to mental health 
services. A limitation is that it does not allow for determination of symptom severity or impact on daily living and 
unlike the HADS screen, it does not screen for other mental health conditions such as anxiety. Indeed, depression 
screening should ideally be followed by further assessment, diagnosis and treatment, if necessary. We did not 
assess the impact of case finding via the BCD on the subsequent management of patients, and therefore cannot 
determine in what proportion of patients this screening led to a formal diagnosis of depression.
Figure 1. Adults with type 2 diabetes and likely depression.
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It is possible that the cross-sectional association we report may be bidirectional. Patients with depression may 
be more prone to diabetes, or alternatively people with diabetes may be more vulnerable to depression. For exam-
ple, while some prospective studies have found that depressive symptoms are associated with a 60% increased 
risk of diabetes34 others report a 24% increased risk of depression in patients with diabetes35. Further research is 
Factor Univariable Analysis Multivariable Analysis
N = 2211 OR (95%CI) p value OR (95%CI) p value
Age
Per 1 year 
increase 0.97 (0.97–0.98) <0.001 0.99 (0.98–1.00) 0.086
Sex
Male (ref)
Female 1.27 (1.07–1.50) 0.007 0.96 (0.77–1.18) 0.672
Non-English speaking2
Yes (ref)
No 1.10 (0.74–1.64) 0.638
Diabetes Duration
1 year increase 1.00 (0.99–1.01) 0.945
HbA1c1%
per unit increase 1.11 (1.06–1.16) <0.001 0.99 (0.94–1.05) 0.849
Sufficient physical activity3
No (ref)
Yes 0.51 (0.42–0.62) <0.001 0.84 (0.67–1.05) 0.123
Difficulties following dietary recommendations
No (ref)
Yes 2.38 (2.00–2.83) <0.010 1.42 (1.14–1.78) 0.002
Current smoking
No (ref)
Yes 1.97 (1.54–2.51) <0.001 1.46 (1.08–1.97) 0.013
Insulin use
No (ref)
Yes 1.53 (1.28–1.82) <0.001 1.11 (0.88–1.39) 0.376
Forgets medications
No (ref)
Yes 2.28 (1.90–2.74) <0.001 1.47 (1.16–1.85) 0.001
Monitors blood glucose as recommended
No (ref)
Yes 0.70 (0.58–0.85) <0.001 1.00 (0.79–1.27) 0.998
Unsure of 
recommended 
testing
0.90 (0.62–1.31) 0.592 1.22 (0.77–1.94) 0.405
Treated for depression4
No (ref)
Yes 3.34 (2.76–4.03) <0.001 2.22 (1.77–2.79) <0.001
Own health rating (1–100)
per 1 point 
increase 0.96 (0.96–0.97) <0.001 0.97 (0.97–0.98) <0.001
Diabetes Distress5
No
Yes 7.20 (5.13–10.11) <0.001 3.18 (2.16–4.69) <0.001
Diabetes Specialist6
No (ref)
Yes 1.14 (0.95–1.36) 0.159
Diabetes Educator6
No (ref)
Yes 1.13 (0.93–1.37) 0.220
Table 2. Factors associated with Likely Depression#. 1Within 6 months of survey.  2Defined as requirement of 
interpreter for appointment. 3Sufficient physical activity for health benefit is defined as ≥150 total minutes per 
week. 4Undergoing counselling or prescribed antidepressant medications. 5As indicated by Diabetes Distress 17 
Score. 6Attended within the last 12 months. #As indicated by the Brief Case-Find for Depression (BCD).
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required to elucidate the direction and underlying mechanisms linking diabetes36 and depression. Some studies 
suggest that diagnosed diabetes is associated with depression but undiagnosed is not37 whereas other studies 
report that both diagnosed and undiagnosed diabetes are associated with depression, suggesting physiologi-
cal rather than psychological mechanisms38. The limited data examining the relationship between depression 
and HbA1c levels show mixed results39. One study found elevated HbA1c levels among people with diabetes 
and depression compared with people with diabetes and no depression40 whilst other studies found either no 
Factor Univariable Analysis Multivariable Analysis
N = 2206 OR (95%CI) p value OR (95%CI) p value
Age
Per 1 year 
increase 0.96 (0.95–0.97) <0.001 0.98 (0.96–0.99) 0.006
Sex
Male (ref)
Female 1.99 (1.45–2.72) <0.001 1.59 (1.11–2.27) 0.012
Duration
1 year increase 1.00 (0.99–1.02) 0.891
HbA1c1%
per unit increase 1.30 (1.21–1.40) <0.001 1.18 (1.07–1.29) <0.001
Insulin use
No (ref)
Yes 2.29 (1.62–3.26) <0.001 1.56 (1.02–2.37) 0.039
Current smoking
No (ref)
Yes 1.77 (1.19–2.63) 0.005 0.83 (0.51–1.33) 0.436
Forgets medications
No (ref)
Yes 3.00 (2.20–4.09) <0.001 1.20 (0.82–1.75) 0.339
Difficulties following dietary recommendations
No (ref)
Yes 4.54 (3.23–6.36) <0.001 2.25 (1.52–3.32) <0.001
Sufficient physical activity3
No (ref)
Yes 0.36 (0.25–0.53) <0.001 0.72 (0.47–1.12) 0.149
Monitors blood glucose as recommended
No (ref)
Yes 0.45 (0.33–0.61) <0.001 0.67 (0.46–0.98) 0.038
Unsure of 
recommended 
testing
0.44 (0.21–0.93) 0.032 0.45 (0.18–1.13) 0.091
Depression5
No
Yes 7.20 (5.13–10.11) <0.001 3.35 (2.26–4.95) <0.001
Treated for depression4
No (ref)
Yes 2.58 (1.89–3.53) <0.001 1.21 (0.84–1.77) 0.308
Own health rating (1–100)
per 1 point 
increase 0.96 (0.95–0.96) <0.001 0.97 (0.96–0.98) <0.001
Diabetes Specialist6
No (ref)
Yes 1.22 (0.88–1.69) 0.233
Diabetes Educator6
No (ref)
Yes 0.80 (0.58–1.12) 0.191
Table 3. Factors associated with Diabetes Distress#. 1Within 6 months of survey. 2Defined as requirement of 
interpreter for appointment. 3Sufficient physical activity for health benefit is defined as ≥150 total minutes per 
week. 4Undergoing counselling or prescribed antidepressant medications. 5As indicated by the Brief Case-Find 
for Depression (BCD). 6Attended within the last 12 months. #As indicated by Diabetes Distress 17 Score.
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relationship between HbA1c levels and depression41. Yet others indicate that HbA1c is correlated with depression 
among people with short but not long term depression39. Some studies have also observed a relationship exists 
between HbA1c levels and depression among people using insulin but not for those using non-insulin hypogly-
caemic agents42. Furthermore, studies report that pharmacotherapy for the treatment of depression may lead 
to poorer diabetes control and adverse metabolic indices43, although this may vary with the medication used44. 
Understanding these complex relationships may lead to better management strategies and therefore improved 
outcomes for patients with co-morbid depression and diabetes.
Diabetes Distress. Diabetes distress needs to be differentiated from depression due to differences in the origins 
and appropriate management19. The 17-item Diabetes Distress Scale (DDS17) is a widely used and validated meas-
ure for assessing diabetes-specific distress, with high reliability and validity across many settings, countries and cul-
tures27,45–47. The DDS17 items can be used to identify areas of specific patient concern, to enable clinicians to initiate 
discussions that acknowledge and address diabetes-related difficulties, provide reassurance and initiate behavioural 
change. Studies indicate that this is most successful when the conversation is initiated by clinicians48. Timely detec-
tion and management of diabetes distress is associated with better self-care, quality of life and health outcomes20. 
The rate of diabetes distress in our study is comparable to that reported in other studies. We also found that most of 
the distress reported was in the domains of regimen-related distress and emotional burdens: ‘feeling that they will 
end up with serious long-term complications regardless of what they do’ and that ‘diabetes and/or hypertension are 
consuming to much of their mental and physical energy’ followed by ‘feeling that they are not closely adhering to a 
good meal plan’. In studies conducted in Denmark49, China50 and Mexico46, regimen-related distress and emotional 
burden were also a greater source of diabetes distress than interpersonal or physician related distress.
Depression and Distress. Depression and diabetes distress can decrease adherence to self-care practices, 
and in turn, contribute to higher HbA1c levels51. Patients with depression are also less likely to discuss self-care 
practices with health professionals52. Here, we report that HbA1c was associated with diabetes distress, but was 
not associated with depression after adjustment for other potential confounders. This is likely due to depressive 
symptoms hindering diabetes self-care, even in patients with symptoms insufficient to make the diagnosis of major 
depression36. We found that diabetes distress but not depression was associated with insulin use after adjustment for 
other potential confounders. Others53 have similarly reported a positive association between diabetes distress and 
insulin use rather than depression in Turkey and China30, suggesting the relationships are consistent across cultures.
Strengths and Limitations. A strength of this analysis is the nation-wide survey with a large dataset of 
patients. Data were sourced from the majority of centres registered with the National Association of Diabetes 
centres (NADC). Thus participants of our study are likely to be representative of patients attending diabetes cen-
tres. We obtained information on a broad range of variables with potential impact on mental health. Limitations 
include that the majority of patients received care at tertiary diabetes centres and may differ from a primary care 
treated patient group. Further, referral bias is also possible as general practitioners may be more likely to refer 
more challenging patients whilst managing other patients with better control; skewing results towards a more 
complex patient cohort with more significant mental health concerns. Alternatively, patients with interrelating 
co-morbid psychological conditions may also be more likely to be referred. Another limitation was the reliance 
on self/healthcare worker reports as we were unable to independently verify diagnoses and treatments. This is 
unlikely to change our findings substantively, as previous research has found approximately 90% of self-reported 
diabetes information to be valid54. We were unable to conduct longitudinal analyses to identify the direction of the 
reported relationships as the data were obtained in a de-identified format. Our study highlights the need for fur-
ther prospective studies to examine cause and effect. Our study population was predominantly Australian-born 
and English speaking, our findings may not be generalisable to other populations. However, the requirement for 
an interpreter was not associated with either depression or diabetes distress. There was insufficient ethnic vari-
ation in our study population for analysis by ethnicity. The BCD is a categorical measure and does not indicate 
the severity of depression; further studies are required to elucidate if the degree of glycaemic control is associated 
with the severity of depression. We did not obtain data for the patients who refused or were unable to answer the 
questions informing this analysis, thus we have no clear indication if or how non-response could have altered our 
results. However, non-response was rather low (5%).
Conclusion
The findings of this study emphasise the importance of screening for and addressing emotional and psychological 
health in people with type 2 diabetes, and highlight the need for longitudinal data to elucidate the determinants of 
depression and diabetes distress in type 2 diabetes. Given the high prevalence of depression and diabetes distress, 
routine screening of patients with type 2 diabetes should be encouraged to optimise mental health and improve 
quality of life.
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